Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02740816 · ClinicalTrials.gov registry record
Comparative Study of Menstrual Blood and Systemic Blood
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 35
- Enrollment target
NCT02740816: Completed study, sponsored by Stanford University.
NCT02740816 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02740816 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The purpose is to investigate how menstrual blood differs from systemic blood to evaluate if menstrual blood could be utilized as a natural and non-invasive access to blood for regular health monitoring and early diagnostics.
Primary Outcome
The following biomarkers will be tested for and then compared for systemic blood and menstrual blood: * BUN * Sodium * Potassium * Chloride * Glucose * Calcium * HDL * LDL * Triglycerides * CRP * Estradiol * Ferritin * A1c * Hemoglobin * Hepatic function panel * TSH * FSH * T3
Interventions
- OTHER Comparative blood analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-03 |
What the finished NCT02740816 record still lists
NCT02740816 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Comparative blood analysis is the first listed.
NCT02740816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02740816 about?
NCT02740816 is a clinical study titled "Comparative Study of Menstrual Blood and Systemic Blood". The purpose is to investigate how menstrual blood differs from systemic blood to evaluate if menstrual blood could be utilized as a natural and non-invasive access to blood for regular health monitoring and early diagnostics.
What is the current status of trial NCT02740816?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2016-03. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02740816?
The interventions under investigation include: Comparative blood analysis (OTHER).
Who is sponsoring clinical trial NCT02740816?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia